The landscape of antibody therapeutic development is undergoing a profound transformation, driven by the accelerating integration of artificial intelligence (AI)…
Read More

The landscape of antibody therapeutic development is undergoing a profound transformation, driven by the accelerating integration of artificial intelligence (AI)…
Read More
Raleigh, NC — Michelle Itano, Editor-in-Chief of BioTechniques and a distinguished researcher at the University of North Carolina, Chapel Hill,…
Read More
The genetic stability of recombinant Chinese hamster ovary (CHO) cell lines, which serve as the primary workhorses for producing a…
Read More
Chapel Hill, NC – Michelle Itano, the esteemed Editor-in-Chief hailing from the University of North Carolina, Chapel Hill, has unveiled…
Read More